Murskautuminen

4 ms·

1.
Four Decisions: The Divergent Choices That Define a Life(gadallon.substack.com)
2 points by Murskautuminen 5mo ago|0 comments
2.
by Murskautuminen 8mo ago
20260216 For future reference: https://www.nature.com/articles/d41586-025-03967-9 Seemed relevant in this thread.
3.
by Murskautuminen 8mo ago
I agree with your points overall. Regarding "what is a journal except for a complicated algorithm for performing reviews"? I think one point is that there is a hard-to-quantify social contract between the journal editors and spec
4.
by Murskautuminen 8mo ago
I think for smaller software papers or ML learning on arxiv this might work. For larger papers on biomedical or hard-tech, I think it is much less likely. I struggle to keep up with BioRxiv.org as a medical professional, many articles would
5.
by Murskautuminen 8mo ago
I am afraid that gatekeeping is partially essential and somewhat desired, as an academic you don't have time to read everything and some sort of quick signals, albeit very flawed, can be useful to stop wasting time reading crappy scien
6.
by Murskautuminen 2y ago
Thanks for sharing a great article. Overall, I think the path to develop a drug is very multi-dimensional, cost and time intensive and very slow. Some other elements to add to the article: - The preclinical drug discovery phase was not ment
7.
by Murskautuminen 2y ago
Actually, the term opperhoofd was used by chief ranking officers of the Dutch trading companies in Japan. https://en.wikipedia.org/wiki/VOC_opperhoofden_in_Japan
8.
by Murskautuminen 3y ago
Some products also only make money after a long time of R&D. If you are a startup focused on such a product, R&D tax benefits are critical to keep you alive during your long development time that will require multiple rounds of inve
9.
Opinion: Play-to-earn feels like a disaster waiting to happen(gamedeveloper.com)
2 points by Murskautuminen 5y ago|0 comments